文献速递神经肿瘤

超越手术边缘:世界卫生组织2级颅内脑膜瘤的复发模式

Beyond the Surgical Margin: Patterns of Recurrence in World Health Organization Grade 2 Intracranial Meningiomas.
PubMed 文献 · World Neurosurg · 2023-06-28

该回顾性研究纳入1996至2019年在本机构接受手术切除、术后未接受辅助放疗且随后出现复发的22例新诊断WHO 2级颅内脑膜瘤患者,比较全切除(GTR)与次全切除(STR)后的复发位置模式。结果显示复发多位于中央区和/或原肿瘤边缘,仅少数复发位于原肿瘤边缘外超过1 cm。作者认为在安全前提下手术切除或辅助放疗包含至少1 cm的硬膜边缘可能有助于优化肿瘤控制,但需进一步临床研究。

要点

  • 22例未接受辅助放疗的WHO 2级脑膜瘤复发患者中,GTR组12例(55%),STR组10例(45%)。
  • GTR组中央复发10例(83.3%)、边缘复发11例(91.7%)、远处复发4例(33.3%)。
  • STR组中央复发9例(90.0%)、边缘复发10例(100.0%)、远处复发4例(40.0%)。

核心结论

  • 本研究表明WHO 2级脑膜瘤手术切除(GTR或STR)后复发多位于中央区和/或原肿瘤边缘,仅少数复发位于原肿瘤边缘外超过1 cm。
  • 作者认为在安全前提下初始手术切除或辅助放疗包含至少1 cm的硬膜边缘可能有助于优化肿瘤控制,但需进一步临床研究。

研究设计与样本

  • 回顾性综述1996年至2019年在本机构接受新诊断WHO 2级脑膜瘤手术切除的患者。
  • 纳入术后观察未接受辅助放疗且随后出现复发的患者,排除所有接受辅助治疗者。
  • 共22例患者符合纳入标准,其中12例(55%)接受GTR,10例(45%)接受STR。
  • 复发定义为术后监测磁共振成像上任何影像学进展证据。
  • 复发位置分为中央生长(原切除肿瘤区域内、原肿瘤边缘内超过1 cm)、边缘生长(原肿瘤边缘内或外1 cm内)和远处生长(原肿瘤边缘外超过1 cm),由2名观察者在配准术前和术后磁共振成像后评估,差异通过讨论解决。

主要发现

  • GTR组12例患者术前平均肿瘤体积为50.6 cm3,其中5例(41.7%)位于颅底;平均复发时间22.7个月,平均复发肿瘤体积9.0 cm3。
  • GTR组中央复发10例(83.3%)、边缘复发11例(91.7%)、远处复发4例(33.3%)。
  • STR组10例患者术前平均肿瘤体积为44.8 cm3,其中7例(70.0%)位于颅底;平均复发时间23.0个月,平均复发肿瘤体积21.8 cm3。
  • STR组中央复发9例(90.0%)、边缘复发10例(100.0%)、远处复发4例(40.0%)。

关键数值与推荐

  • 复发位置分类:中央生长为原切除肿瘤区域内、原肿瘤边缘内超过1 cm;边缘生长为原肿瘤边缘内或外1 cm内;远处生长为原肿瘤边缘外超过1 cm。
  • GTR组:中央复发10例(83.3%),边缘复发11例(91.7%),远处复发4例(33.3%)。
  • STR组:中央复发9例(90.0%),边缘复发10例(100.0%),远处复发4例(40.0%)。

临床怎么用

  • 作者认为在安全前提下初始手术切除或辅助放疗包含至少1 cm的硬膜边缘可能有助于优化肿瘤控制,但需进一步临床研究。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize and classify the location of recurrence in surgically resected World Health Organization (WHO) grade 2 intracranial meningiomas that did not receive adjuvant radiation and compare the recurrence pattern of those who underwent gross total resection (GTR) versus subtotal resection (STR). METHODS: We performed a retrospective review of patients who underwent surgical resection of a newly diagnosed WHO grade 2 meningioma at our institution between 1996 and 2019. Patients who were observed postoperatively without adjuvant radiation and subsequently developed a recurrence were included in the study. All patients who received adjuvant therapy were excluded. Recurrence was defined as any evidence of radiographic progression on postoperative surveillance magnetic resonance imaging. Location of recurrence was categorized as follows: 1) central-growth observed inside the area of the previously resected tumor more than 1 cm inside the original tumor margin; 2) marginal-growth observed within 1 cm (inside or outside) of the original tumor margin; and 3) remote-growth observed >1 cm outside the original tumor margin. Patterns of recurrence were evaluated by 2 observers after coregistering preoperative and postoperative magnetic resonance imaging, and any differences were reconciled by discussion. RESULTS: A total of 22 patients matched the inclusion criteria. Twelve (55%) underwent GTR, and 10 (45%) underwent STR. In 12 patients in whom GTR was achieved, the mean preoperative tumor volume was 50.6 cm3, with 5 (41.7%) in a skull base location. The average time to recurrence for these tumors was 22.7 months, with a mean recurrent tumor volume of 9.0 cm3. Ten patients (83.3%) had central recurrence, 11 patients (91.7%) had marginal recurrence, and only 4 patients (33.3%) had remote recurrence. In 10 patients in whom STR was achieved, mean preoperative tumor volume was 44.8 cm3, with 7 (70.0%) in a skull base location. The average time to recurrence for these tumors was 23.0 months, with a mean recurrent tumor volume of 21.8 cm3. Of these 10 patients, 9 (90.0%) had central recurrence, all 10 (100.0%) had marginal recurrence, and only 4 (40.0%) patients had remote recurrence. CONCLUSIONS: The present study evaluating patterns of recurrence for WHO grade 2 meningiomas after surgical resection (GTR or STR) showed that recurrence occurred centrally and/or at the original tumor margin, with only a few recurring >1 cm outside the original tumor margin. The results of this study suggest that treatment, whether initial surgical resection or adjuvant radiation, may benefit from including at least a 1-cm dural margin when safe, to optimize tumor control, but further clinical study is needed.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Obiri-Yeboah D, Soni P, Oyem PC, et al. Beyond the Surgical Margin: Patterns of Recurrence in World Health Organization Grade 2 Intracranial Meningiomas. World Neurosurg. 2023. PMID: 37390903. doi:10.1016/j.wneu.2023.06.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。